Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010

BC-3781 is a novel semisynthetic pleuromutilin antibiotic inhibiting bacterial protein synthesis. BC-3781 has completed a phase 2 clinical trial in acute bacterial skin and skin structure infections (ABSSSI). Its antibacterial spectrum additionally covers the predominant pathogens causing community-...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Paukner, Susanne, Sader, Helio S., Ivezic-Schoenfeld, Zrinka, Jones, Ronald N.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2013
Ämnen:
Epidemiology and Surveillance
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754340/
https://ncbi.nlm.nih.gov/pubmed/23836172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00358-13
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk